NantHealth, Providence Health to Establish Clinical WGS Program for Cancer Patients | GenomeWeb

NEW YORK (GenomeWeb) – NantHealth, The Chan Soon-Shiong Institute of Molecular Medicine, and Providence Health and Services will partner to create a clinical network for whole-genome sequencing.

The organizations have installed an Illumina HiSeq X Ten sequencing system and plan to establish a CLIA-approved facility to use sequencing to help guide treatment decisions for cancer patients. The clinical lab will be located at NantOmics in Culver City, Calif., and will have the capacity for 22 HiSeq X Ten systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.